MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Hologic Company Profile (NASDAQ:HOLX)

Consensus Ratings for Hologic (NASDAQ:HOLX) (?)
Ratings Breakdown: 8 Hold Rating(s), 11 Buy Rating(s)
Consensus Rating:Buy (Score: 2.58)
Consensus Price Target: $42.77 (25.56% upside)

Analysts' Ratings History for Hologic (NASDAQ:HOLX)
Show:
DateFirmActionRatingPrice TargetActions
6/22/2016Bank of AmericaReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/21/2016Jefferies GroupReiterated RatingBuy$42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/4/2016Morgan StanleyReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/29/2016Goldman SachsReiterated RatingConviction-Buy -> Buy$45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016Canaccord GenuityReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016Leerink SwannReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016Needham & Company LLCDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/17/2016Piper JaffrayReiterated RatingNeutral$38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/31/2016William BlairReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/28/2016JPMorgan Chase & Co.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/28/2016BTIG ResearchReiterated RatingBuy$43.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/7/2016BarclaysBoost Price TargetEqual Weight$40.00 -> $42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/11/2015Stifel NicolausUpgradeHold -> Buy$45.00 -> $45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/26/2015GabelliInitiated CoverageBuy$43.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/21/2015Craig HallumDowngradeBuy -> Hold$42.00 -> $37.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/3/2015ArgusReiterated RatingBuy$43.00 -> $52.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/13/2015Evercore Partners Inc.Reiterated RatingBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/13/2015Evercore ISIDowngradeBuy -> Hold$37.50 -> $38.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/1/2015Cowen and CompanyBoost Price TargetMarket Perform$35.00 -> $40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/25/2015RBC CapitalBoost Price TargetSector Perform$31.00 -> $32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/5/2014Barrington ResearchDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/31/2014SunTrustReiterated RatingR$15.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/2/2014Standpoint ResearchDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/30/2014 forward)
Earnings History for Hologic (NASDAQ:HOLX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/27/2016        
4/27/2016Q216$0.46$0.47$686.82 million$693.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/27/2016Q116$0.42$0.46$688.68 million$695.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2015Q415$0.42$0.43$691.94 million$702.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/29/2015Q315$0.39$0.43$653.85 million$693.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/29/2015Q215$0.39$0.41$646.49 million$655.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/28/2015Q115$0.36$0.39$630.79 million$652.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2014Q414$0.37$0.38$636.20 million$660.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2014Q314$0.34$0.37$621.89 million$632.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2014Q214$0.33$0.37$609.35 million$625.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/3/2014Q114$0.31$0.34$609.65 million$612.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/11/2013Q413$0.37$0.39$624.40 million$622.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2013Q3 2013$0.37$0.38$627.05 million$626.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2013Q2 2013$0.34$0.35$639.53 million$619.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/4/2013Q1 2013$0.37$0.38$646.52 million$644.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/12/2012Q412$0.36$0.37$581.12 million$600.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2012$0.34$0.35ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2012$0.33$0.33ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/30/2012$0.32$0.34ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2011$0.33$0.34ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/1/2011$0.32$0.32ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2011$0.28$0.30ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/31/2011$0.28$0.30ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Hologic (NASDAQ:HOLX)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164$0.45$0.46$0.45
Q2 20162$0.47$0.48$0.48
Q3 20165$0.47$0.48$0.47
Q4 20163$0.49$0.49$0.49
(Data provided by Zacks Investment Research)
Dividend History for Hologic (NASDAQ:HOLX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Hologic (NASDAQ:HOLX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/1/2016Lawrence M LevyDirectorSell17,794$34.41$612,291.54View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/27/2016Peter J Valenti IIIInsiderSell10,022$33.83$339,044.26View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/26/2016Elaine UllianDirectorSell6,896$33.85$233,429.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/26/2016Karleen Marie ObertonVPSell4,228$33.85$143,117.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/24/2016David R Lavance JrDirectorSell11,621$34.50$400,924.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/10/2015Lawrence M. LevyDirectorSell20,000$40.70$814,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/21/2015Lawrence M. LevyDirectorSell5,000$42.02$210,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/8/2015Wayne WilsonDirectorSell100,000$39.00$3,900,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/28/2015Wayne WilsonDirectorSell11,146$39.70$442,496.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2015Wayne WilsonDirectorSell25,080$38.61$968,338.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2015Wayne WilsonDirectorSell13,257$42.20$559,445.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2015Lawrence M LevyDirectorSell10,000$36.45$364,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/22/2015Lawrence M LevyDirectorSell5,000$35.05$175,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/4/2015Lawrence M LevyDirectorSell10,000$34.36$343,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/6/2015David R Lavance JrDirectorSell12,000$32.12$385,440.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/13/2015David R Lavance JrDirectorSell8,000$30.32$242,560.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/29/2015Karleen Marie ObertonVPSell18,997$30.00$569,910.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/11/2014Karleen Marie ObertonVPSell2,609$26.30$68,616.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014Karleen Marie ObertonVPSell12,507$26.83$335,562.81View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/31/2014Roger D MillsSVPSell14,506$26.00$377,156.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/9/2014Elaine UllianDirectorBuy7,900$25.36$200,344.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/9/2014Rohan HastieSVPSell6,037$24.36$147,061.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/8/2014Glenn MuirCFOSell50,000$24.26$1,213,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/6/2014Glenn MuirCFOSell196,000$23.29$4,564,840.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/6/2014Lawrence LevyDirectorSell5,052$23.58$119,126.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/6/2014Robert LavalleeCAOSell22,796$23.58$537,529.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/14/2014David Lavance, Jr.DirectorSell5,500$21.49$118,195.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/14/2014Glenn MuirCFOSell160,000$21.51$3,441,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/7/2014Mark CaseyCAOSell3,251$22.53$73,245.03View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/11/2014Stephen MacmillanCEOBuy38,600$21.58$832,988.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/7/2014Stephen MacmillanCEOBuy198,900$20.78$4,133,142.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/13/2013Robert LavalleeCAOSell15,677$21.70$340,190.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/30/2013Glenn P MuirCFOSell140,000$22.32$3,124,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/15/2013Glenn P MuirCFOSell28,000$22.12$619,360.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/16/2013Glenn MuirCFOSell28,000$20.45$572,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/13/2013Robert LavalleeCAOSell2,500$20.33$50,825.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/20/2013David BradySVPSell42,328$22.80$965,078.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/15/2013Glenn MuirCFOSell28,000$22.49$629,720.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/8/2013Lawrence LevyDirectorSell5,000$22.50$112,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/8/2013Mark CaseyCAOSell14,804$22.57$334,126.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/19/2013Robert H LavalleeCAOSell11,254$20.89$235,096.06View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2013Glenn P MuirCFOSell28,000$19.78$553,840.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2013Robert CascellaCEOSell20,000$19.55$391,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/17/2013Glenn P MuirCFOSell28,000$21.42$599,760.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2013Robert CascellaCEOSell20,000$20.71$414,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/25/2013Lawrence M LevyDirectorSell5,000$22.00$110,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/5/2012Glenn P MuirCFOSell68,750$19.96$1,372,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/8/2012Glenn P MuirCFOSell68,750$19.69$1,353,687.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Hologic (NASDAQ:HOLX)
DateHeadline
06/29/16 07:16 AMNew Broker Ratings For Hologic, Inc. (NASDAQ:HOLX) - FTSE News
06/28/16 04:25 PMHologic, Inc. (NASDAQ:HOLX): Reviewing Stock Performance - Press Telegraph
06/28/16 04:25 PMTarget Price Consensus Focus on Hologic, Inc. (NASDAQ:HOLX) - Press Telegraph
06/28/16 04:25 PMHC Stocks Newsbeat: Allergan plc Ordinary Shares (NYSE:AGN), Hologic, Inc. (NASDAQ:HOLX) - share market updates (press release)
06/28/16 04:25 PMHologic, Inc. (NASDAQ:HOLX) Company Rating and Target Watch - Telanagana Press
06/28/16 09:20 AMShares in Decline this Year Hologic Inc. (NASDAQ:HOLX) - Press Telegraph
06/27/16 04:25 PMWatching Stock Sentiment for:Hologic, Inc. (NASDAQ:HOLX) - Press Telegraph
06/27/16 04:25 PMHologic, Inc. (NASDAQ:HOLX) Broker Price Targets For The Coming Week - Fiscal Standard
06/27/16 08:51 AMEye Catching Stock: Hologic Inc. (NASDAQ:HOLX) - News Oracle
06/27/16 08:51 AMCurrent Analysts Rating Update: Hologic, Inc. (NASDAQ:HOLX) , Medtronic plc (NYSE:MDT) - Street Updates
06/24/16 04:30 PMMEDNAX Stock Up On Accretive Acquisitions & Collaborations
06/24/16 10:35 AMHologic Inc. (HOLX) is Trading Higher on Unusual Volume for June 22
06/24/16 07:38 AMHologic, Inc. breached its 50 day moving average in a Bullish Manner : HOLX-US : June 24, 2016 -
06/23/16 09:42 PMHologic : Affirm™ Prone Biopsy System Featured at Premier Inc. Annual Innovation Celebration
06/23/16 03:43 PMHologic, Inc. (NASDAQ:HOLX): Share Update and Performance Review - Press Telegraph
06/23/16 03:43 PMStrong Sell Calls Recommendations For Hologic, Inc. (NASDAQ:HOLX) At 0 - Investor Newswire
06/23/16 03:43 PMLast Analysts Rating Review: MannKind Corporation (NASDAQ:MNKD) , Hologic, Inc. (NASDAQ:HOLX) - Street Updates
06/23/16 03:43 PMHologic Inc (NASDAQ:HOLX) close to 52-week low, short interest dropping - Street Report
06/23/16 01:35 PMHologic calls follow bullish momentum -
06/23/16 07:22 AMHot Stocks - Harmony Gold Mining, (NYSE:HMY), Hologic, (NASDAQ:HOLX) - Hot Stocks Point
06/22/16 04:19 PMHologic’s Affirm™ Prone Biopsy System Featured at Premier Inc. Annual Innovation Celebration - [at noodls] - Hologic's Affirm™ Prone Biopsy System Featured at Premier Inc. Annual Innovation Celebration MARLBOROUGH, Mass., June 22, 2016 -- Hologic, Inc. (Nasdaq: HOLX) announced today that the Company's Affirm™ ...
06/22/16 07:51 AMHologic: FDA Okays Procleix Zika Virus Test under IND Study -
06/21/16 10:24 AM​Zika virus test by Hologic gets FDA's OK for emergency use -
06/21/16 09:03 AMTwo Movers inside Analysts Radar: Exelixis, Inc. (NASDAQ:EXEL) , Hologic, Inc. (NASDAQ:HOLX) - Street Updates
06/20/16 04:49 PMFDA Approves Use Of Zika Virus Blood Screener From Hologic And Grifols - Hologic Inc (NASDAQ: HOLX) and Grifols, S.A. (NASDAQ: GRFS) announced Monday that they won FDA approval for the use of the Procleix Zika virus blood ...Full story available on Benzinga.com
06/20/16 04:17 PMBuzz Stocks: Apple Inc., Hologic, Inc., and JD.Com Inc - Schaeffers Research (blog)
06/20/16 04:17 PMHC Stocks Reports Analysis: Hologic, Inc. (NASDAQ:HOLX), MannKind Corporation (NASDAQ:MNKD) - share market updates (press release)
06/20/16 10:54 AMHologic And Grifols Get FDA Approval For Procleix Zika Virus Assay - Hologic, Inc. (NASDAQ: HOLX) and Grifols (NASDAQ: GRFS) disclosed Monday that the U.S. Food and Drug Administration has approved use of the Procleix Zika virus blood screening assay on the Procleix Panther system under the agency's Investigational New Drug (IND) trial protocol. According to Hologic and Grifols, ...Full story available on Benzinga.com
06/20/16 10:40 AMFDA Okays Procleix Zika Virus Assay From Hologic, Grifols To Screen Blood Supply
06/20/16 10:40 AMHologic's Zika Virus Test Gets FDA Nod for Emergency Use
06/20/16 10:40 AMHologic's (HOLX) Aptima Zika Virus Assay Granted FDA Emergency Use Authorization
06/19/16 04:05 PMHologic, Inc. (NASDAQ:HOLX) Analyst Price Targets For The Coming Week - Fiscal Standard
06/19/16 08:42 AMHologic gets FDA 'emergency' use OK for Zika virus test
06/19/16 08:42 AMHologic wins emergency U.S. authorization for Zika test | Reuters
06/19/16 08:42 AMFDA Grants Emergency Use Authorization for Hologic's Aptima® Zika Virus Assay
06/16/16 04:31 PMSelling Boundary Nears To- Viacom (NASDAQ:VIAB), Hologic (NASDAQ:HOLX), Patriot National (NYSE:PN) - Seneca Globe
06/16/16 04:31 PMStrong Buy Calls Count For Hologic, Inc. (NASDAQ:HOLX) At 9 - Investor Newswire
06/16/16 04:31 PMHologic, Inc. (NASDAQ:HOLX) & Valeant Pharmaceuticals Intl (NYSE:VRX) Healthcare Stocks Intraday Alert - Wall Street 24
06/16/16 08:45 AMCurrent Price Targets For Marinus Pharmaceuticals, Inc. (MRNS)
06/15/16 04:30 PMAnalysis under consideration: Hologic Inc. (NASDAQ:HOLX) - News Oracle
06/15/16 04:30 PMStocks Showing Movement: Vista Gold Corp. (NYSEMKT:VGZ), Hologic Inc. (NASDAQ:HOLX) - Beacon Chronicle
06/15/16 09:06 AMKLAS Report Shows Hologic Continuing to Lead the U.S. Breast Tomosynthesis Market with Genius 3D MAMMOGRAPHY Exams
06/15/16 09:06 AMHologic : KLAS Report Shows Hologic Continuing to Lead the U.S. Breast Tomosynthesis Market with Genius™ 3D MAMMOGRAPHY™ Exams
06/15/16 07:19 AMKLAS Report Shows Hologic Continuing to Lead the U.S. Breast Tomosynthesis Market with Genius™ 3D MAMMOGRAPHY™ Exams - [at noodls] - Mammography customers highlight Hologic's high image quality, strong customer support, and market-leading product innovations MARLBOROUGH, Mass., June 15, 2016/PRNewswire / -- Hologic (NASDAQ: HOLX) announced ...
06/14/16 08:05 AMHow Are IHI’s Holdings’ Moving Averages Trending? -
06/13/16 04:12 PMAnalyst Buzz: Hologic Inc. (NASDAQ:HOLX) - News Oracle
06/13/16 01:45 PMHologic, Inc. – Value Analysis (NASDAQ:HOLX) : June 13, 2016 -
06/13/16 07:13 AMPrice Target Summary: Hologic Inc. (NASDAQ:HOLX), Relypsa, Inc. (NASDAQ:RLYP) - Beacon Chronicle
06/10/16 04:38 PMHC Stocks in Hub: UnitedHealth Group Inc (NYSE:UNH), Hologic, Inc. (NASDAQ:HOLX) - share market updates (press release)
06/10/16 04:37 PMHologic Inc (NASDAQ:HOLX): Big Market Mover - Street Report
About Hologic

Hologic logoHologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women's health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. Its Diagnostics products include its Aptima family of assays, which run on its advanced instrumentation systems (Panther and Tigris); ThinPrep system; the Rapid Fetal Fibronectin Test, and Procleix blood screening assays. Its Breast Health products include a portfolio of breast imaging and related products and accessories, including digital mammography systems, computer-aided detection for mammography and minimally invasive breast biopsy devices, breast biopsy site markers and breast biopsy guidance systems. Its GYN Surgical products include NovaSure Endometrial Ablation System and MyoSure Hysteroscopic Tissue Removal System. Its Skeletal Health segment offers Discovery and Horizon X-ray bone densitometers.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: HOLX
  • CUSIP: 43644010
Key Metrics:
  • Previous Close: $34.06
  • 50 Day Moving Average: $33.94
  • 200 Day Moving Average: $35.14
  • P/E Ratio: 48.04
  • P/E Growth: 1.79
  • Market Cap: $9.50B
  • Current Quarter EPS Consensus Estimate: $1.91 EPS
Additional Links:
Hologic (NASDAQ:HOLX) Chart for Thursday, June, 30, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha